VAXIMM AG Alternatives & Competitors

12 companies similar to VAXIMM AG — Developing innovative oral T-cell immunotherapies to treat cancer patients

Jounce Therapeutics, Inc.

Daring to create a world immune to cancer.

18 Post-IPO Equity $194.25M

Cambridge, United States

Biotechnology Health and Wellness +1

Eureka Therapeutics, Inc

45 Grant $139.50M

Emeryville, United States

Biotechnology Health Care +1

Imvax, Inc.

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...

24 $253.70M

Philadelphia, United Stat...

Biotechnology Health and Wellness +1

Korecyte Bio

We provide the tools to make cell therapy safer and more effective for treating solid tumo...

London, United Kingdom

Biotechnology Health and Wellness

Track all VAXIMM AG competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Boostimmune

Developing breakthrough therapies to fight cancer by harnessing the power of the immune sy...

Venture round

Biotechnology Health Care +1

Carisma Therapeutics

Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors

15 Acquired $101.00M

Philadelphia, United Stat...

Biotechnology Health Care +2

OXVax Ltd

Developing a Next Generation Cancer Vaccine

2-10 Seed

Oxford, United Kingdom

Biotechnology Health and Wellness

Umoja Biopharma

Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...

9 Series C $363.00M

Biopharma Biotechnology +2

Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

4013 Acquired $12.56B

Santa Monica, United Stat...

Biotechnology Health Care +1

Enara Bio

Advancing cancer immunotherapy by targeting the unconventional

66 Series B $50.00M

Oxford, United Kingdom

Biotechnology Health Care +1

Abcuro, Inc

Developing immunotherapies for autoimmune diseases and cancer

43 Series B $214.85M

Biotechnology Health Care +1

CatalYm GmbH

Developing innovative immunotherapies to transform cancer patients’ lives by engaging thei...

56 Series D $250.00M

Germany

Biotechnology Health Care +1

About VAXIMM AG

VAXIMM AG is a biotech startup that aims to revolutionize cancer treatment through the development of innovative oral T-cell immunotherapies. Founded in 2008 and headquartered in Switzerland, VAXIMM AG has made significant strides in its field. The company's lead product candidate, oral VXM01, has shown promise in acti...

Business keywords

Biotech, Cancer Treatment, Immunotherapy, Oral T-cell Immunotherapies, Clinical Development, Collaboration Agreements, Vaccines, Tumor Vasculature, Antibody Therapy, Brain Cancer, China Medical System Holdings, Swiss/German Biotech Company, Basel, Switzerland, Mannheim, Germany

Frequently Asked Questions

Companies similar to VAXIMM AG include Jounce Therapeutics, Inc., Eureka Therapeutics, Inc, Imvax, Inc., Korecyte Bio, Boostimmune. They work in Biotechnology and Health and Wellness and share VAXIMM AG's focus on immunotherapy, cancer treatment and biotech.

Bounce Watch lists 12 companies that share VAXIMM AG's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches VAXIMM AG and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

VAXIMM AG Profile Eureka Therapeutics, Inc Alternatives Imvax, Inc. Alternatives Korecyte Bio Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at VAXIMM AG on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.